Canaccord Genuity analysts reiterated a Buy rating on Boston Scientific Corporation (NYSE:BSX) on February 17, 2026. Boston Scientific Corporation operates in the Healthcare…
Canaccord Genuity analysts reiterated a Buy rating on Boston Scientific Corporation (NYSE:BSX) on February 17, 2026.
Boston Scientific Corporation operates in the Healthcare sector. The stock currently trades at $76.28 with a market capitalization of $136.0B.
Current market data
NYSE · BSX
$43.92
Down: -$0.76 · -1.70%
Live quote updated
Keep reading
insider ·
insider ·
institutional ·
sec_filing ·
